BerGenBio ASA
OSE:BGBIO.OL
0.152 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -190.401 | -302.122 | -309.364 | -257.029 | -199.278 | -191.747 | -182.208 | -129.799 | -72.107 | -57.78 |
| Depreciation & Amortization
| 0.223 | 0.883 | 1.312 | 0.726 | 0.785 | 0.204 | 0.193 | 0.207 | 0.179 | 0.179 |
| Deferred Income Tax
| 0 | 0 | 0.668 | 0.709 | 10.41 | 0 | 0 | 0 | 0.001 | -0.001 |
| Stock Based Compensation
| 3.135 | 3.466 | 7.113 | 7.412 | 3.842 | 1.678 | 2.314 | 5.702 | 5.576 | 1.988 |
| Change In Working Capital
| -33.389 | 9.21 | 0.061 | 17.506 | 10.506 | 3.158 | 11.592 | -0.443 | 3.217 | 1.805 |
| Accounts Receivables
| -1.622 | -3.462 | 1.83 | 1.59 | 2.013 | -4.401 | -1.128 | -4.263 | 1.086 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -31.809 | 13.641 | 3.27 | 11.982 | 11.151 | 5.847 | 14.543 | 5.919 | 1.584 | 0 |
| Other Working Capital
| -31.767 | -0.969 | -5.039 | 3.934 | -2.658 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| -3.055 | 0.332 | -3.13 | -3.614 | -10.41 | 0.001 | -12.538 | 0.019 | 0.232 | 0.094 |
| Operating Cash Flow
| -225.101 | -288.231 | -303.34 | -234.29 | -184.145 | -186.706 | -168.109 | -124.314 | -62.902 | -53.715 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | -0.067 | 0 | -0.228 | -0.34 | -0.255 | 0 | 0 |
| Acquisitions Net
| 0 | 0.299 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 3.055 | 2.949 | 0 | 3.615 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 3.055 | 3.248 | 3.13 | 3.548 | 0 | -0.228 | -0.34 | -0.255 | 0 | 0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -0.193 | 0 | 0 | 0 | 0 | 0 | 0 | -1.307 | -1.307 | 0 |
| Common Stock Issued
| 262.048 | 3.218 | 16.629 | 740.852 | 82.785 | 190.525 | 402.296 | 212.22 | 9.231 | 167.959 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | -25.322 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -37.164 | -0.314 | -0.634 | -41.345 | -5.468 | -13.527 | 0 | 1.489 | 11.845 | 0 |
| Financing Cash Flow
| 224.884 | 2.904 | 15.995 | 699.507 | 77.317 | 176.998 | 376.974 | 212.402 | 10.538 | 167.959 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 2.78 | -3.764 | -0.779 | -0.71 | 0 | 0 | 0 | -0.001 | 0 | 0 |
| Net Change In Cash
| 5.618 | -285.843 | -284.995 | 468.055 | -106.828 | -9.936 | 208.525 | 87.832 | -52.364 | 114.244 |
| Cash At End Of Period
| 156.421 | 150.803 | 436.646 | 721.641 | 253.586 | 360.414 | 370.35 | 161.825 | 73.993 | 126.357 |